- Table of Contents
This method entails modifying genetic material outside of an organism in order to acquire improved and desired features in living creatures or their products. This approach entails the insertion of DNA fragments from a number of sources into a vector with a desired gene sequence.
Recombinant proteins are proteins that have been encoded by recombinant DNA that has been cloned into an expression vector that facilitates gene expression and messenger RNA translation. The expression of a mutant protein can be induced by modifying the gene using recombinant DNA technology. Recombinant protein is a modified form of native protein that is produced in a variety of methods to boost protein output, change gene sequences, and manufacture useful commercial products. Transfection of foreign genes into a host cell results in the formation of recombinant proteins. Recombinant proteins are frequently utilized to manufacture pharmaceutical goods, protein-based polymers for drug delivery, antibodies and enzymes for disease treatment, and protein scaffolds for tissue engineering, among other applications.
Recombinant proteins are frequently utilized to manufacture pharmaceutical goods, protein-based polymers for drug delivery, antibodies and enzymes for disease treatment, and protein scaffolds for tissue engineering, among other applications.
The concept of recombinant DNA and the mechanism for manufacturing it were developed by Stanford University graduate student Peter Lobban. Together with his professor, Dale Kaiser, they published their hypotheses in the journal Enzymatic end-to-end joining of DNA molecules in 1973, elucidating the procedure for separating and amplifying genes and re-inserting them into a new host cell. Stanford University filed a patent application in 1974 (together with Stanley Cohen and Herbert Boyer as inventors), which was granted in 1980. Three years later, further technological developments followed, including Herbert Boyer's invention of biosynthetic human insulin.
Today, the US Food and Drug Administration has approved over 130 recombinant proteins for clinical use. Nevertheless, over 170 recombinant proteins are generated and employed in medicine on a global scale.
In cells, protein synthesis occurs in two stages: transcription and translation, which is referred to as the central dogma of molecular biology. In other words, transcription and translation are processes in the expression of recombinant proteins. The gene is extracted and cloned into an expression vector to generate recombinant proteins. To generate a recombinant protein, an expression system, a purification system, and a protein identification system are required.
For all expression systems, the process is substantially the same. A DNA sequence coding for the protein of interest, a vector into which the DNA sequence is put, and an appropriate host that will express the foreign DNA sequence are the basic needs.
Despite their identical methodology, the application breadth of expression systems differs. Each of the five most widely used systems has its own set of benefits and drawbacks. As a result, the choice of expression system is crucial in the creation of recombinant proteins. The nature of the heterologous protein to be expressed determines the expression system to use.
You must select a specific expression vector for the expression system. You must first pick which system will be used to express your protein of interest before selecting an expression vector.
The only thing to think about is whether you're dealing with a large or small DNA fragment. For ease of manipulation, vectors must be relatively tiny molecules. The replication of large vectors may be hampered, and stability issues may arise.
If you want to purify the protein after expression, the expression vector may include a purification tag such as His, Myc, FLAG, etc. In any case, whether a C-terminal or N-terminal tag is needed depends on the specific needs of experiments.
Promoters are required to build expression vectors. A powerful promoter is required in some circumstances, while a typical promoter is required in others. TEF1 is a strong constitutive promoter in yeast, while ADH1 is a medium constitutive promoter and STE1 is a weak constitutive promoter.
Other tags and fusion proteins may be included in expression vectors, depending on the downstream uses of the target protein. A unique tag can be useful for studying the function of a target protein as well as protein-protein interactions. Tags and fusion proteins are valuable tools for conducting Western Blotting, immunoprecipitation, pull-down assay (proteins binding in vitro assay), and other investigations to better understand the function of the target protein.
A selectable marker is a gene that transmits a phenotype to host cells harboring the target gene that is suited for artificial selection (recombinant vector). In summary, the selectable marker gene aids in the identification and screening of positive transformants (the cells that take in recombinant vector). Which host cell type you use determines whether you have a selectable marker choice. Antibiotic resistance genes are frequently used as selectable markers. Beta-lactamase, for example, confers ampicillin resistance to bacterial hosts.
A recombinant protein purification is a significant tool in biological research. Researchers must separate and purify the recombinant protein from the organism in order to understand its function and structure. The similarity and difference between distinct recombinant proteins are mostly used in the protein purification technique. Based on the similarities between proteins, non-proteinaceous elements can be eliminated, and the target recombinant protein can then be extracted and purified based on the differences between proteins.
To separate proteins, analytical purification typically employs three features. First, proteins can be purified using a pH-graded gel or an ion-exchange column to determine their isoelectric points. Second, size exclusion chromatography or SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) analysis can be used to separate proteins based on their size or molecular weight. Proteins are frequently isolated using 2D-PAGE and then examined using peptide mass fingerprinting to determine their identity. This is particularly beneficial for scientific applications, as protein detection limits are now quite low, and only a few nanograms of protein are required for analysis.
Protein tags are a helpful and convenient method for enhancing recombinant protein solubility, speeding protein purification, and tracking proteins throughput protein expression and purification.
Protein tags can also be used to track proteins and processes in living cells, either directly or indirectly, using Western blot, immunoprecipitation, or immunostaining.
Adding a tag on a protein provides it a binding affinity that it wouldn't have otherwise. The recombinant protein is usually the sole protein in the mixture with this affinity, making separation easier. The Histidine-tag (His-tag), which possesses an affinity for nickel or cobalt ions, is the most prevalent tag. Affinity support that exclusively binds to histidine-tagged proteins can thus be generated by immobilizing nickel or cobalt ions on a resin.